Literature DB >> 15726611

Intra-arterial bolus octreotide administration during Whipple procedure in patients with fragile pancreas: a novel technique for safer pancreaticojejunostomy.

Manousos M Konstadoulakis1, George M Filippakis, Emmanuel Lagoudianakis, Pantelis T Antonakis, Chris Dervenis, John Bramis.   

Abstract

BACKGROUND AND OBJECTIVES: Leakage from the pancreaticojujenostomy is the most serious complication of Whipple. Pancreatic fistula rate is higher in cases of fragile pancreas often seen in duodenal carcinomas and carcinomas of the ampulla of Vater. Octreotide administration has been used for the prevention of fistula formation through the subcutaneous route. Due to its physiologic effects to the pancreatic parenchyma the intra-arterial administration of octreotide could provide tissue hardening that allows for a technically easier anastomosis while maintaining its protective role for fistula formation.
METHODS: Octreotide was injected directly into the distal part of the gastroduodenal artery (GDA) in four patients undergoing Whipple for histologically proven periampullary cancer.
RESULTS: Tissue hardening after octreotide administration was evident not only in surgeons' hands but in the intra-operative ultrasound as well. The three patients were discharged on day 9, 11, and 13; they had an uneventful postoperative course, while one patient had a minor bile leak from the choledojejunal anastomosis and was discharged on day 22.
CONCLUSIONS: The intra-arterial administration of octreotide during Whipple is a safe procedure and provides tissue hardening thus making the performance of the anastomosis technically easier. The actual benefit in terms of morbidity, mortality, and fistula rate are to be further evaluated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15726611     DOI: 10.1002/jso.20193

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

Review 1.  Therapeutic strategies for the management of delayed gastric emptying after pancreatic resection.

Authors:  Dimitrios Lytras; Kosmas I Paraskevas; Costas Avgerinos; Costas Manes; Zisis Touloumis; Konstantina D Paraskeva; Christos Dervenis
Journal:  Langenbecks Arch Surg       Date:  2006-10-05       Impact factor: 3.445

2.  Octreotide hardens the pancreas.

Authors:  T Foitzik; M Gock; C Schramm; F Prall; E Klar
Journal:  Langenbecks Arch Surg       Date:  2006-03-28       Impact factor: 3.445

Review 3.  Developing Risk Prediction Models for Postoperative Pancreatic Fistula: a Systematic Review of Methodology and Reporting Quality.

Authors:  Zhang Wen; Ya Guo; Banghao Xu; Kaiyin Xiao; Tao Peng; Minhao Peng
Journal:  Indian J Surg       Date:  2016-01-23       Impact factor: 0.656

4.  A simple scoring system based on clinical factors related to pancreatic texture predicts postoperative pancreatic fistula preoperatively.

Authors:  Ulrich Friedrich Wellner; Gian Kayser; Hryhoriy Lapshyn; Olivia Sick; Frank Makowiec; Jens Höppner; Ulrich Theodor Hopt; Tobias Keck
Journal:  HPB (Oxford)       Date:  2010-12       Impact factor: 3.647

5.  Anatomy-specific pancreatic stump management to reduce the risk of pancreatic fistula after pancreatic head resection.

Authors:  Yoshitsugu Tajima; Tamotsu Kuroki; Noritsugu Tsuneoka; Tomohiko Adachi; Taiichiro Kosaka; Tatsuya Okamoto; Mitsuhisa Takatsuki; Susumu Eguchi; Takashi Kanematsu
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

6.  Focal change of the pancreatic texture using a direct injection mixture of N-butyl cyanoacrylate and lipiodol in the pig model: a strategy for preventing pancreatic leakage during pancreatic surgery.

Authors:  Eun Young Kim; Tae Ho Hong
Journal:  Ann Surg Treat Res       Date:  2018-09-28       Impact factor: 1.859

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.